Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

AIMS/HYPOTHESIS: Observational studies suggest that metformin may reduce cancer risk by approximately one-third. We examined cancer outcomes and all-cause mortality in published randomised controlled trials (RCTs). METHODS: RCTs comparing metformin with active glucose-lowering therapy or placebo/usu...

Full description

Bibliographic Details
Main Authors:	Stevens, R, Ali, R, Bankhead, C, Bethel, M, Cairns, B, Camisasca, R, Crowe, F, Farmer, A, Harrison, S, Hirst, J, Home, P, Kahn, SE, Mclellan, J, Perera, R, Plüddemann, A, Ramachandran, A, Roberts, N, Rose, P, Schweizer, A, Viberti, G, Holman, R
Format:	Journal article
Language:	English
Published:	2012

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Similar Items